| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2013 | On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs | Wu C.-C.; Li Y.-C.; Wang Y.-R.; TSAI-KUN LI ; Chan N.-L. | Nucleic Acids Research | 111 | 109 | |
| 2019 | The paracrine induction of prostate cancer progression by caveolin-1 | Lin C.-J.; Yun E.-J.; Lo U.-G.; Tai Y.-L.; Deng S.; Hernandez E.; Dang A.; Chen Y.-A.; Saha D.; Mu P.; Lin H.; TSAI-KUN LI ; Shen T.-L.; Lai C.-H.; Hsieh J.-T. | Cell Death and Disease | 20 | 20 | |
| 2007 | Prazosin displays anticancer activity against human prostate cancers: Targeting DNA and cell cycle | Lin S.-C.; Chueh S.-C.; Hsiao C.-J.; TSAI-KUN LI ; Chen T.-H.; Liao C.-H.; Lyu P.-C.; Guh J.-H. | Neoplasia | 55 | 55 | |
| 2017 | Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt(II)-methionine coordination chemistry | Wang Y.-R.; Chen S.-F.; Wu C.-C.; Liao Y.-W.; Lin T.-S.; Liu K.-T.; Chen Y.-S.; TSAI-KUN LI ; Chien T.-C.; Chan N.-L. | Nucleic Acids Research | 42 | 38 | |
| 2012 | QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells | Chen M.-C.; Pan S.-L.; Shi Q.; Xiao Z.; Lee K.-H.; TSAI-KUN LI ; Teng C.-M. | Cancer Science | 12 | 12 | |
| 2018 | Regioselective synthesis and biological evaluation of: N -substituted 2-aminoquinazolin-4-ones | Liao Z.-Y.; Yeh W.-H.; Liao P.-Y.; Liu Y.-T.; Chen Y.-C.; Chen Y.-H.; Hsieh T.-H.; Lin C.-C.; Lu M.-H.; Chen Y.-S.; Hsu M.-C.; TSAI-KUN LI ; Chien T.-C. | Organic and Biomolecular Chemistry | 9 | 9 | |
| 2020 | Retraction notice to “Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases” [Eur. J. Med. Chem. 190 (2020) 112074] (European Journal of Medicinal Chemistry (2020) 190 (S0223523420300416), (10.1016/j.ejmech.2020.112074)) | Lee J.-F.; Chang T.-Y.; Liu Z.-F.; Lee N.-Z.; Yeh Y.-H.; Chen Y.-S.; Chen T.-C.; Chou H.-S.; TSAI-KUN LI ; Lee S.-B.; Lin M.-H. | European Journal of Medicinal Chemistry | 0 | 0 | |
| 2016 | Rhapontigenin inhibits TGF-β-mediated epithelial-mesenchymal transition via the PI3K/AKT/mTOR pathway and is not associated with HIF-1α degradation | Yeh Y.-H.; Wang S.-W.; Yeh Y.-C.; Hsiao H.-F.; TSAI-KUN LI | Oncology Reports | 17 | 19 | |
| 2020 | The role of extracellular vesicles in prostate cancer with clinical applications | Tai Y.-L.; Lin C.-J.; TSAI-KUN LI ; Shen T.-L.; Hsieh J.-T.; Chen B.P.C. | Endocrine-Related Cancer | 7 | 5 | |
| 2012 | Rottlerin potentiates camptothecin-induced cytotoxicity in human hormone refractory prostate cancers through increased formation and stabilization of topoisomerase I-DNA cleavage complexes in a PKCδ-independent pathway | Hsu J.-L.; Ho Y.-F.; TSAI-KUN LI ; Chen C.-S.; Hsu L.-C.; Guh J.-H. | Biochemical Pharmacology | 18 | 15 | |
| 2020 | Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase–negative cells | Zencir S.; Hsieh M.-H.; Hsu J.-S.; Ergun Y.; Chou G.-L.; TSAI-KUN LI ; Teng S.-C.; Topcu Z. | Journal of Cancer Research and Clinical Oncology | 3 | 3 | |
| 1998 | Selective cytotoxicity of topoisomerase-directed protoberberines against glioblastoma cells | Sanders M.M.; Liu A.A.; TSAI-KUN LI ; Wu H.-Y.; Desai S.D.; Mao Y.; Rubin E.H.; LaVoie E.J.; Makhey D.; Liu L.F. | Biochemical Pharmacology | 51 | ||
| 2003 | Single-stranded DNA induces ataxia telangiectasia mutant (ATM)/p53-dependent DNA damage and apoptotic signals | Nur-E-Kamal A.; TSAI-KUN LI ; Zhang A.; Qi H.; Hars E.S.; Liu L.F. | Journal of Biological Chemistry | 46 | 42 | |
| 2010 | Sodium salicylate acts through direct inhibition of phosphoinositide 3-kinase-like kinases to modulate topoisomerase-mediated DNA damage responses | Fan J.-R.; Huang T.-H.; Wen C.-Y.; Shen T.-L.; TSAI-KUN LI | European Journal of Pharmacology | 4 | 4 | |
| 2011 | Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide | Wu C.-C.; TSAI-KUN LI ; Farh L.; Lin L.-Y.; Lin T.-S.; Yu Y.-J.; Yen T.-J.; Chiang C.-W.; Chan N.-L. | Science | 335 | 329 | |
| 2003 | Substituted benzo[i]phenanthridines as mammalian topoisomerase-targeting agents | Makhey D.; Li D.; Zhao B.; Sim S.-P.; TSAI-KUN LI ; Liu A.; Liu L.F.; LaVoie E.J. | Bioorganic and Medicinal Chemistry | 43 | ||
| 2003 | Substituted dibenzo[c,h]cinnolines: Topoisomerase I-targeting anticancer agents | Yu Y.; Singh S.K.; Liu A.; TSAI-KUN LI ; Liu L.F.; LaVoie E.J. | Bioorganic and Medicinal Chemistry | 84 | 83 | |
| 2014 | Synergistic property of cordycepin in cultivated Cordyceps militaris-mediated apoptosis in human leukemia cells | Chou S.-M.; Lai W.-J.; Hong T.-W.; Lai J.-Y.; Tsai S.-H.; Chen Y.-H.; Yu S.-H.; Kao C.-H.; Chu R.; Ding S.-T.; TSAI-KUN LI ; Shen T.-L. | Phytomedicine | 29 | 23 | |
| 2008 | Synthesis, DNA binding, and cytotoxicity of 1,4-bis(2-amino-ethylamino)anthraquinone-amino acid conjugates | Hsin L.-W.; Wang H.-P.; Kao P.-H.; Lee O.; Chen W.-R.; Chen H.-W.; Guh J.-H.; Chan Y.-L.; His C.-P.; Yang M.-S.; TSAI-KUN LI ; Lee C.-H. | Bioorganic and Medicinal Chemistry | 45 | 41 | |
| 2015 | Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers | Hsieh M.-H.; Tsai C.-H.; Lin C.-C.; TSAI-KUN LI ; Hung T.-W.; Chang L.-T.; Hsin L.-W.; Teng S.-C. | Cellular and Molecular Life Sciences | 5 | 6 |
